Bringing the fundamentals into focus…
Back to Kiniksa Pharmaceuticals International, plc
How Kiniksa Pharmaceuticals International, plc stacks up
KNSA · against 184 other Healthcare companies of similar size
Growth
97/ 100
Near the top of its peers.
Ranked #5 of 185 · scores higher than 97% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 90–100, including KNSA · Click a bar to see the companies
Why growth scores 97?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 44.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 92% of peers. Revenue growth: 58.9% vs peer median 6.1%
- faster growth in earnings per share: stronger than 99% of peers. Earnings per share growth: 1473.7% vs peer median 9.8%
Metric by metric
Position: dot = KNSA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KNSA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 185 reported | 58.9% | 9.5% | 91% | 33% | |
| Earnings per share growthHigher is better · 126 reported | 1473.7% | 12.8% | 99% | 33% | |
| 3-year revenue growthHigher is better · 179 reported | 44.1% | 9.6% | 89% | 33% |
Ranking by growth score
Top 5 and the companies ranked around KNSA| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 3.8B USD | 98 | 71 | |
| 2 | 9.3B USD | 98 | 64 | |
| 5 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 5 | 4.0B USD | 97 | 56 | |
| 5 | 7.3B USD | 97 | 74 | |
| 8 | 14.5B USD | 96 | 30 | |
| 8 | 5.7B USD | 96 | 52 | |
| 10 | 9.0B USD | 95 | 51 | |
| 10 | 4.7B USD | 95 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score